INSMED INC Increase (Decrease) in Accounts Receivable
INSMED INC (INSM) reported Increase (Decrease) in Accounts Receivable of $75.35 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-06
- INSMED INC increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $37.16M, a 505.01% increase year-over-year.
- INSMED INC increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $38.19M.
- INSMED INC increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $77.30M, a 554.14% increase year-over-year.
- INSMED INC increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $10.23M, a 29117.14% increase year-over-year.
- INSMED INC increase (decrease) in accounts receivable for fiscal 2025 was $88.31M, a 582.86% increase from fiscal 2024.
- INSMED INC increase (decrease) in accounts receivable for fiscal 2024 was $12.93M, a 8.10% increase from fiscal 2023.
- INSMED INC increase (decrease) in accounts receivable for fiscal 2023 was $11.96M, a 86.25% increase from fiscal 2022.
- INSMED INC increase (decrease) in accounts receivable for fiscal 2022 was $6.42M, a 20.88% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $75.35M 10-Q · filed 2026-08-06 | $152.65M derived: sum of 3 quarters · filed 2026-08-06 | $162.88M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $38.19M 10-Q · filed 2026-05-07 | $115.49M derived: sum of 2 quarters · filed 2026-05-07 | $125.72M derived: sum of 3 quarters · filed 2026-05-07 | $131.86M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $77.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $87.53M derived: sum of 2 quarters · filed 2026-02-19 | $93.67M derived: sum of 3 quarters · filed 2026-08-06 | $88.31M 10-K · filed 2026-02-19 | ||
| 2025-09-30 | $10.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $16.37M derived: sum of 2 quarters · filed 2026-08-06 | $11.01M 10-Q · filed 2025-10-30 | $22.82M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $6.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $781.00K 10-Q · filed 2026-08-06 | $12.60M derived: sum of 3 quarters · filed 2026-08-06 | $12.63M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | -$5.36M 10-Q · filed 2026-05-07 | $6.46M derived: sum of 2 quarters · filed 2026-05-07 | $6.49M derived: sum of 3 quarters · filed 2026-05-07 | $10.53M derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $11.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $11.85M derived: sum of 2 quarters · filed 2026-02-19 | $15.89M derived: sum of 3 quarters · filed 2026-02-19 | $12.93M 10-K · filed 2026-02-19 | ||
| 2024-09-30 | $35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $4.07M derived: sum of 2 quarters · filed 2025-10-30 | $1.11M 10-Q · filed 2025-10-30 | $5.65M derived: sum of 4 quarters · filed 2026-02-19 | ||
| 2024-06-30 | $4.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.08M 10-Q · filed 2025-08-07 | $5.62M derived: sum of 3 quarters · filed 2026-02-19 | $10.75M derived: sum of 4 quarters · filed 2026-02-19 | ||
| 2024-03-31 | -$2.96M 10-Q · filed 2025-05-08 | $1.58M derived: sum of 2 quarters · filed 2026-02-19 | $6.72M derived: sum of 3 quarters · filed 2026-02-19 | $8.15M derived: sum of 4 quarters · filed 2026-02-19 | ||
| 2023-12-31 | $4.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $9.67M derived: sum of 2 quarters · filed 2026-02-19 | $11.10M derived: sum of 3 quarters · filed 2026-02-19 | $11.96M 10-K · filed 2026-02-19 | ||
| 2023-09-30 | $5.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $6.57M derived: sum of 2 quarters · filed 2024-10-31 | $7.43M 10-Q · filed 2024-10-31 | $8.41M derived: sum of 4 quarters · filed 2025-02-20 | ||
| 2023-06-30 | $1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $2.29M 10-Q · filed 2024-08-08 | $3.27M derived: sum of 3 quarters · filed 2025-02-20 | $1.93M derived: sum of 4 quarters · filed 2025-02-20 | ||
| 2023-03-31 | $860.00K 10-Q · filed 2024-05-09 | $1.84M derived: sum of 2 quarters · filed 2025-02-20 | $499.00K derived: sum of 3 quarters · filed 2025-02-20 | $5.49M derived: sum of 4 quarters · filed 2025-02-20 | ||
| 2022-12-31 | $983.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | -$361.00K derived: sum of 2 quarters · filed 2025-02-20 | $4.63M derived: sum of 3 quarters · filed 2025-02-20 | $6.42M 10-K · filed 2025-02-20 | ||
| 2022-09-30 | -$1.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $3.64M derived: sum of 2 quarters · filed 2023-10-26 | $5.44M 10-Q · filed 2023-10-26 | $10.68M derived: sum of 4 quarters · filed 2024-02-22 | ||
| 2022-06-30 | $4.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $6.78M 10-Q · filed 2023-08-03 | $12.03M derived: sum of 3 quarters · filed 2024-02-22 | $13.05M derived: sum of 4 quarters · filed 2024-02-22 | ||
| 2022-03-31 | $1.80M 10-Q · filed 2023-05-04 | $7.04M derived: sum of 2 quarters · filed 2024-02-22 | $8.06M derived: sum of 3 quarters · filed 2024-02-22 | $8.85M derived: sum of 4 quarters · filed 2024-02-22 | ||
| 2021-12-31 | $5.24M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $6.26M derived: sum of 2 quarters · filed 2024-02-22 | $7.05M derived: sum of 3 quarters · filed 2024-02-22 | $8.12M 10-K · filed 2024-02-22 | ||
| 2021-09-30 | $1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $1.81M derived: sum of 2 quarters · filed 2022-10-27 | $2.88M 10-Q · filed 2022-10-27 | $4.24M derived: sum of 4 quarters · filed 2023-02-23 | ||
| 2021-06-30 | $789.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.85M 10-Q · filed 2022-08-04 | $3.22M derived: sum of 3 quarters · filed 2023-02-23 | $3.24M derived: sum of 4 quarters · filed 2023-02-23 | ||
| 2021-03-31 | $1.07M 10-Q · filed 2022-05-05 | $2.43M derived: sum of 2 quarters · filed 2023-02-23 | $2.46M derived: sum of 3 quarters · filed 2023-02-23 | $474.00K derived: sum of 4 quarters · filed 2023-02-23 | ||
| 2020-12-31 | $1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $1.39M derived: sum of 2 quarters · filed 2023-02-23 | -$592.00K derived: sum of 3 quarters · filed 2023-02-23 | -$2.67M 10-K · filed 2023-02-23 | ||
| 2020-09-30 | $23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | -$1.96M derived: sum of 2 quarters · filed 2021-10-28 | -$4.04M 10-Q · filed 2021-10-28 | -$150.00K derived: sum of 4 quarters · filed 2022-02-17 | ||
| 2020-06-30 | -$1.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$4.06M 10-Q · filed 2021-08-05 | -$173.00K derived: sum of 3 quarters · filed 2022-02-17 | $3.54M derived: sum of 4 quarters · filed 2022-02-17 | ||
| 2020-03-31 | -$2.08M 10-Q · filed 2021-05-06 | $1.81M derived: sum of 2 quarters · filed 2022-02-17 | $5.52M derived: sum of 3 quarters · filed 2022-02-17 | $7.81M derived: sum of 4 quarters · filed 2022-02-17 | ||
| 2019-12-31 | $3.89M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $7.59M derived: sum of 2 quarters · filed 2022-02-17 | $9.88M derived: sum of 3 quarters · filed 2022-02-17 | $13.72M 10-K · filed 2022-02-17 | ||
| 2019-09-30 | $3.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $6.00M derived: sum of 2 quarters · filed 2020-10-29 | $9.83M 10-Q · filed 2020-10-29 | $15.35M derived: sum of 4 quarters · filed 2021-02-25 | ||
| 2019-06-30 | $2.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $6.12M 10-Q · filed 2020-08-06 | $11.64M derived: sum of 3 quarters · filed 2021-02-25 | $11.64M derived: sum of 4 quarters · filed 2021-02-25 | ||
| 2019-03-31 | $3.83M 10-Q · filed 2020-04-30 | $9.35M derived: sum of 2 quarters · filed 2021-02-25 | $9.35M derived: sum of 3 quarters · filed 2021-02-25 | $9.35M derived: sum of 4 quarters · filed 2021-02-25 | ||
| 2018-12-31 | $5.51M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $5.51M derived: sum of 2 quarters · filed 2021-02-25 | $5.51M derived: sum of 3 quarters · filed 2021-02-25 | $5.51M 10-K · filed 2021-02-25 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $0.00 derived: sum of 2 quarters · filed 2019-10-30 | $0.00 10-Q · filed 2019-10-30 | |||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $0.00 10-Q · filed 2019-08-01 | ||||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-07 | |||||
| 2017-12-31 | $0.00 10-K · filed 2020-02-25 | |||||
| 2016-12-31 | $0.00 10-K · filed 2019-02-22 | |||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $0.00 derived: sum of 2 quarters · filed 2015-02-27 | $0.00 derived: sum of 3 quarters · filed 2015-02-27 | -$757.00K 10-K · filed 2015-02-27 | ||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $0.00 derived: sum of 2 quarters · filed 2013-11-05 | -$757.00K 10-Q · filed 2013-11-05 | -$440.00K derived: sum of 4 quarters · filed 2014-03-06 | ||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | -$757.00K 10-Q · filed 2013-08-06 | -$440.00K derived: sum of 3 quarters · filed 2014-03-06 | -$303.00K derived: sum of 4 quarters · filed 2014-03-06 | ||
| 2012-03-31 | -$757.00K 10-Q · filed 2013-05-07 | -$440.00K derived: sum of 2 quarters · filed 2014-03-06 | -$303.00K derived: sum of 3 quarters · filed 2014-03-06 | -$169.00K derived: sum of 4 quarters · filed 2014-03-06 | ||
| 2011-12-31 | $317.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-06 | $454.00K derived: sum of 2 quarters · filed 2014-03-06 | $588.00K derived: sum of 3 quarters · filed 2014-03-06 | $286.00K 10-K · filed 2014-03-06 | ||
| 2011-09-30 | $137.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $271.00K derived: sum of 2 quarters · filed 2012-11-07 | -$31.00K 10-Q · filed 2012-11-07 | $31.00K 10-Q · filed 2011-11-09 | -$117.00K derived: sum of 4 quarters · filed 2013-03-18 | |
| 2011-06-30 | $134.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$168.00K 10-Q · filed 2012-08-07 | $168.00K 10-Q/A · filed 2011-08-08 | -$254.00K derived: sum of 3 quarters · filed 2013-03-18 | -$242.00K derived: sum of 4 quarters · filed 2013-03-18 | |
| 2011-03-31 | -$302.00K 10-Q · filed 2012-05-08 | -$388.00K derived: sum of 2 quarters · filed 2013-03-18 | -$376.00K derived: sum of 3 quarters · filed 2013-03-18 | |||
| 2010-12-31 | -$86.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$74.00K derived: sum of 2 quarters · filed 2013-03-18 | -$19.00K 10-K · filed 2013-03-18 | |||
| 2010-09-30 | $12.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-09 | $67.00K 10-Q · filed 2011-11-09 | ||||
| 2010-06-30 | $55.00K 10-Q/A · filed 2011-08-08 | |||||
| 2009-12-31 | $123.00K 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |